News for 'Reddy Laboratories'

'Omicron produces less severe illness'

'Omicron produces less severe illness'

Rediff.com9 Dec 2021

'What prevents infection are masks, physical distancing and good ventilation.'

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

Glaxo's strategy may limit gains for Indian firms

Glaxo's strategy may limit gains for Indian firms

Rediff.com5 Jan 2009

Dr Reddy's has reached an out-of-court settlement to launch the Glaxo-patented Imitrex, a migraine drug that had annual sales of $878 million as of March 31, 2006, in the US. Experts estimate Dr Reddy's may not get more than $8-$15 million sales in 2009 since majority of sales revenue has to be given to GSK, for allowing the launch the authorised generic version.

Why 1,700 employees of Pfizer's India arm may lose their jobs

Why 1,700 employees of Pfizer's India arm may lose their jobs

Rediff.com10 Jan 2019

A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.

Cyclone Yaas: Amit Shah reviews preparation with CMs of 3 states

Cyclone Yaas: Amit Shah reviews preparation with CMs of 3 states

Rediff.com24 May 2021

Union Home Minister Amit Shah on Monday reviewed the preparations for Cyclone Yaas including the evacuation of people on the high seas as well as in vulnerable coastal areas and the safety of COVID-19 facilities.

Pharma cos splitting R&D units to cut costs

Pharma cos splitting R&D units to cut costs

Rediff.com4 Jun 2008

Ranbaxy Laboratories, Dr Reddy's, Nicholas Piramal and three other Indian drug companies cut their research costs by separating the units involved in developing new drugs, thereby addressing investor concerns on low operating margins.

Markets end flat amid choppy trade; Nifty holds 8,700

Markets end flat amid choppy trade; Nifty holds 8,700

Rediff.com14 Sep 2016

PSU bank shares were the top gainers on hopes of a rate by the RBI on easing consumer inflation

India-made Remdesivir may come out in 10 days

India-made Remdesivir may come out in 10 days

Rediff.com19 Jun 2020

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.

Drug firms bet big on SEZs

Drug firms bet big on SEZs

Rediff.com12 Apr 2006

Matrix Labs' Belgian buy turns sour

Matrix Labs' Belgian buy turns sour

Rediff.com29 Feb 2008

Analysts feel this decision is yet another example of big-ticket acquisitions turning sour for Indian pharma firms, as happened in the case of Dr Reddy's acquisition of Betapharm of Germany for Rs 2,250 crore (Rs 22.5 billion).

India reports record daily spike of 12,881 COVID-19 cases

India reports record daily spike of 12,881 COVID-19 cases

Rediff.com18 Jun 2020

India is the fourth worst-hit nation by the pandemic after the United States, Brazil and Russia.

HC lifts stay on Sun Pharma's $3.2 billion Ranbaxy takeover

HC lifts stay on Sun Pharma's $3.2 billion Ranbaxy takeover

Rediff.com24 May 2014

Both companies can now complete the deal.

Pharma cos on DMF filing spree

Pharma cos on DMF filing spree

Rediff.com12 Jan 2005

India successfully test-fires surface-to-air missile off Odisha coast

India successfully test-fires surface-to-air missile off Odisha coast

Rediff.com3 Jul 2017

Designed to be a quick reaction missile, it has a strike range of 25 km to 30 km.

BrahMos missiles successfully test-fired from land, air

BrahMos missiles successfully test-fired from land, air

Rediff.com18 Dec 2019

A land-attack version of the missile was test-launched from Launch Pad-3 of the Integrated Test Range (ITR). An air force variant was fired from an IAF fighter jet over Bay of Bengal.

Home grown Tejas aircraft given final operational clearance

Home grown Tejas aircraft given final operational clearance

Rediff.com21 Feb 2019

Air Chief Marshal B S Dhanoa calling the FOC a 'major milestone'.

How Paris fell in love with coffee grown by Andhra tribals

How Paris fell in love with coffee grown by Andhra tribals

Rediff.com22 Mar 2017

Retracing the journey that brought coffee from Araku Valley in Andhra Pradesh to an upscale caf in the aristocratic district of Le Marais in Paris.

Pharma industry's most wanted men

Pharma industry's most wanted men

Rediff.com29 Apr 2004

iGenetic Diagnostics: The next generation pathology lab

iGenetic Diagnostics: The next generation pathology lab

Rediff.com12 Apr 2017

When Prashanth Reddy's father was in an ICU he could not find a lab that would deliver a blood infection test report in 24 hours. That's where iGenetic Diagnostics, which uses molecular techniques next generation sequencing, came in.

Covid-19 impact: Low interest loans likely for vaccine companies

Covid-19 impact: Low interest loans likely for vaccine companies

Rediff.com10 Oct 2020

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.

VAT fear may hurt Indian drug firms' March sales

VAT fear may hurt Indian drug firms' March sales

Rediff.com3 Apr 2003

Indian drugmakers' domestic sales of ready-to-take medicines in January-March could be lower than expected as distributors suspended stocking in anticipation of a new value-added tax system coming into force, analysts and industry members said.\n\n\n\n

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Markets end marginally higher even as Fed rate hike looms

Markets end marginally higher even as Fed rate hike looms

Rediff.com14 Jun 2017

Nifty PSU Bank index gained 1% led by Allahabad Bank, Andhra Bank, Syndicate Bank and IDBI Bank

Sensex ends at 27,098 ahead of F&O expiry, Fed meet outcome

Sensex ends at 27,098 ahead of F&O expiry, Fed meet outcome

Rediff.com29 Oct 2014

US stocks rose more than 1% on Tuesday, with the S&P 500 coming less than 2% below its record peak set last month.

Ray of hope? Jaipur's 'safe' lab might redo Maggi study

Ray of hope? Jaipur's 'safe' lab might redo Maggi study

Rediff.com14 Aug 2015

The lab has 18 scientists.

Note ban shadow lingers over one in four BSE 200 stocks

Note ban shadow lingers over one in four BSE 200 stocks

Rediff.com30 Mar 2017

Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.

Why Indian pharma cos are gung-ho about the US mkt

Why Indian pharma cos are gung-ho about the US mkt

Rediff.com24 May 2019

While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products

Dilip Shanghvi's X factor shows up in different ways

Dilip Shanghvi's X factor shows up in different ways

Rediff.com13 Mar 2015

Dilip Shanghvi has never tried to be everything to everybody.

Drug makers oppose ban on diabetes pill

Drug makers oppose ban on diabetes pill

Rediff.com3 Jul 2013

Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.

Markets log best weekly gain in seven years on FII buying

Markets log best weekly gain in seven years on FII buying

Rediff.com5 Mar 2016

Rate sensitive sectors rallied the most led by banks while metals surged on rebound in commodity prices

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

'Cipla has emerged as a great catchment area for talent'

'Cipla has emerged as a great "catchment area" for talent'

Rediff.com20 Aug 2020

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.

Sensex soars 237 points ahead of Brexit poll outcome

Sensex soars 237 points ahead of Brexit poll outcome

Rediff.com23 Jun 2016

Participants will watch out for the Brexit poll outcome in the late morning trades tomorrow.

Amid spike in Covid cases, India boosts health infrastructure

Amid spike in Covid cases, India boosts health infrastructure

Rediff.com28 Mar 2020

Even though the Health Ministry and Indian Council of Medical Research (ICMR) have been insisting that there is 'no solid evidence' of community transmission so far, the government has started scaling up health infrastructure to deal with any situation.

How safe is India Inc for its employees?

How safe is India Inc for its employees?

Rediff.com3 May 2018

Eight of the 30 companies in the BSE Sensex that shared data reported 99 fatalities in 2016-17 against 86 in the previous year. These lives were lost due to industrial accidents at manufacturing facilities. Fatalities owing to road accidents were excluded from the count.

Sensex, Nifty lose their way, end on a negative note

Sensex, Nifty lose their way, end on a negative note

Rediff.com2 Nov 2017

A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.

Global meltdown, oil woes drag Sensex 239 points lower; FOMC eyed

Global meltdown, oil woes drag Sensex 239 points lower; FOMC eyed

Rediff.com13 Jun 2016

Sharp fall in capital goods production and manufacturing activity also dented sentiments.

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com3 Aug 2020

'Social distancing, wearing masks and hygiene should be practised more strictly.'' 'People should not assemble in close spaces as the micro droplets may hang in the air and can last for a longer time.'